Hypothyroidism and the Heart
References
- Klein I Danzi S. Thyroid disease and the heart. Circulation. 2007 Oct 9; 116 15: 1725– 35.
- Ochs N , Auer R , Bauer DC , Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med. 2008 Jun 3; 148 11: 832– 45.
- Razvi S , Shakoor A , Vanderpump M , Weaver JU , Pearce SH. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J Clin Endocrinol Metab. 2008 Aug; 93 8: 2998– 3007.
- Jabbar A , Pingitore A , Pearcs SH , Zaman A , Iervasi G , Razvi S. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017 Jan; 14 1: 39– 55.
- Vargas-Uricoechea H , Bonelo-Perdomo A , Sierra-Torres CH. Effects of thyroid hormones on the heart. Clin Investig Arterioscler. 2014 Nov–Dec; 26 6: 296– 309.
- Pearce SH , Brabant G , Duntas L , 2013 ETA Guideline: Management of Subclinical Hypothyroidism. Eur Thyroid J. 2013 Dec; 2 4: 215– 28.
- Kahaly GJ Dillmann WH. Thyroid hormone action in the heart. Endocr Rev. 2005 Aug; 26 5: 704– 28.
- Rodondi N , Bauer DC , Cappola AR , Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study. J Am Coll Cardiol. 2008 Sep 30; 52 14: 1152– 9.
- Iervasi G , Pingitore A , Landi P , Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation. 2003 Feb 11; 107 5: 708– 13.
- Kim EJ , Lyass A , Wang N , Relation of hypothyroidism and incident atrial fibrillation (from the Framingham Heart Study). Am Heart J. 2014 Jan; 167 1: 123– 6.
- Klein I Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001 Feb 15; 344 7: 501– 9.
- Tribulova N , Knezl V , Shainberg A , Seki S , Soukup T. Thyroid hormones and cardiac arrhythmias. Vascul Pharmacol. 2010 Mar–Apr; 52 3–4: 102– 12.
- Bogazzi F , Tomisti L , Bartalena L , Aghini-Lombardi F , Martino E. Amiodarone and the thyroid: a 2012 update. J Endocrinol Invest. 2012 Mar; 35 3: 340– 8.
- Bogazzi F , Bartalena L , Gasperi M , Braverman LE , Martino E. The various effects of amiodarone on thyroid function. Thyroid. 2001 May; 11 5: 511– 9.
- Batcher EL , Tang XC , Singh BN , Singh SN , Reda DJ , Hershman JM ; SAFE-T Investigators. Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation. Am J Med. 2007 Oct; 120 10: 880– 5.
- Cohen-Lehman J , Dahl P , Danzi S , Klein I. Effects of amiodarone therapy on thyroid function. Nat Rev Endocrinol. 2010 Jan; 6 1: 34– 41.
- Markou K , Georgopoulos N , Kyriazopoulou V , Vagenakis AG. Iodine-Induced hypothyroidism. Thyroid. 2001 May; 11 5: 501– 10.
- Leung AM Braverman LE. Iodine-induced thyroid dysfunction. Curr Opin Endocrinol Diabetes Obes. 2012 Oct; 19 5: 414– 9.
- Cooper DS Biondi B. Subclinical thyroid disease. Lancet. 2012 Mar 24; 379 9821: 1142– 54.
- Imaizumi M , Akahoshi M , Ichimaru S , Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab. 2004 Jul; 89 7: 3365– 70.
- Tseng FY , Lin WY , Lin CC , Subclinical hypothyroidism is associated with increased risk for all-cause and cardiovascular mortality in adults. J Am Coll Cardiol. 2012 Aug 21; 60 8: 730– 7.
- Razvi S , Weaver JU , Vanderpump MP , Pearce SH. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. J Clin Endocrinol Metab. 2010 Apr; 95 4: 1734– 40.
- Boekholdt SM , Titan SM , Wiersinga WM , Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clin Endocrinol (Oxf). 2010 Mar; 72 3: 404– 10.
- Rodondi N , den Elzen WP , Bauer DC , Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. Sep 22; 304 12: 1365– 74.
- Surks MI Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab. 2007 Dec; 92 12: 4575– 82.
- Surks MI Boucai L. Age- and race-based serum thyrotropin reference limits. J Clin Endocrinol Metab. 2010 Feb; 95 2: 496– 502.
- Adrees M , Gibney J , El-Saeity N , Boran G. Effects of 18 months of L-T4 replacement in women with subclinical hypothyroidism. Clin Endocrinol (Oxf). 2009 Aug; 71 2: 298– 303.
- Fadeyev VV , Sytch J , Kalashnikov V , Rojtman A , Syrkin A , Melnichenko G. Levothyroxine replacement therapy in patients with subclinical hypothyroidism and coronary artery disease. Endocr Pract. 2006 Jan–Feb; 12 1: 5– 17.
- Flynn RW , Bonellie SR , Jung RT , MacDonald TM , Morris AD , Leese GP. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab. 2010 Jan; 95 1: 186– 93.
- Razvi S , Weaver J , Butler T , Pearce SH. Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Arch Intern Med. 2012 May 28; 172 10: 811– 7.
DOI: https://doi.org/10.14797/mdcj-13-2-55 | Journal eISSN: 1947-6108
Language: English
Page range: 55 - 59
Published on: Apr 1, 2017
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
© 2017 Maja Udovcic, Raul Herrera Pena, Bhargavi Patham, Laila Tabatabai, Abhishek Kansara, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.